why so low?, page-4

The human trial underway still does not have enough subjects and therefore this will delay the FDA approval process.It would be good if the company would explain why this is so, especially given the recent attention to mesothelioma and James Hardy in the press.

Surely anyone diagnosed with mesothelioma would be very keen to try anything


I do agree it's potential is enormous